Uploaded April 2022 | Updated November 2026, 1 day ago
Potential New Killer Cells for Cancer Immunotherapy
This amazing find by the scientists from Memorial Sloan Kettering Cancer Center holds a lot of potential for immunotherapy of the solid tumors. Let's review
If you like this content and want more, I am doing a special lifetime membership offer. Click here:
drbeen.com/yt-special-p
Want to support this work?:
Buy me a coffee :-) buymeacoffee.com/DrMobeenSyed
Become my patron: patreon.com/mobeensyed?fan_landing=true
PayPal: paypal.me/mobeensyed?locale.x=en_US
My substack: mobeensyedmd.substack.com
#drbeen #koolbeens #CancerTherapy
Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.
URL list from Monday, Apr. 25 2022
FastStats - Older Persons Health
cdc.gov/nchs/fastats/older-american-health.htm
Trends in Causes of Death among Older Persons in the United States (October 2005)
cdc.gov/nchs/data/ahcd/agingtrends/06olderpersons.pdf
Cancer Immunosurveillance by Tissue-Resident Innate Lymphoid Cells and Innate-like T Cells: Cell
cell.com/cell/fulltext/S0092-8674(16)00003-9
Programme of self-reactive innate-like T cell-mediated cancer immunity | Nature
nature.com/articles/s41586-022-04632-1
Scientists identify potential new 'soldier' for cancer immunotherapy -- ScienceDaily
sciencedaily.com/releases/2022/04/220420133616.htm
About Us | Sloan Kettering Institute
mskcc.org/research/ski/about
New T cell immune response discovery points to ‘out-of-box’ cancer therapy options – Endpoints News
endpts.com/new-t-cell-immune-response-discovery-points-to-out-of-box-cancer-therapy-options
Programme of self-reactive innate-like T cell-mediated cancer immunity
en.x-mol.com/paper/article/1516862209619566592
Immune Checkpoint Inhibitors - National Cancer Institute
cancer.gov/about-cancer/treatment/types/immunotherapy/checkpoint-inhibitors
nci-vol-10396-150.jpg (1500×1200)
cancer.gov/sites/g/files/xnrzdm211/files/styles/cgov_enlarged/public/cgov_image/media_image/2019-09/nci-vol-10396-150.jpg?h=30063a04&itok=DGHB7TA1
Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors - PubMed
pubmed.ncbi.nlm.nih.gov/29990692
Definition of CTLA-4 - NCI Dictionary of Cancer Terms - National Cancer Institute
cancer.gov/publications/dictionaries/cancer-terms/def/ctla-4
776560.jpg (3120×2400)
nci-media.cancer.gov/pdq/media/images/776560.jpg
USCS Data Visualizations - CDC
gis.cdc.gov/Cancer/USCS/#/Demographics
FCER1G - Wikipedia
en.wikipedia.org/wiki/FCER1G
Potential New Killer Cells for Cancer Immunotherapy
This amazing find by the scientists from Memorial Sloan Kettering Cancer Center holds a lot of potential for immunotherapy of the solid tumors. Let's review
If you like this content and want more, I am doing a special lifetime membership offer. Click here:
drbeen.com/yt-special-p
Want to support this work?:
Buy me a coffee :-) buymeacoffee.com/DrMobeenSyed
Become my patron: patreon.com/mobeensyed?fan_landing=true
PayPal: paypal.me/mobeensyed?locale.x=en_US
My substack: mobeensyedmd.substack.com
#drbeen #koolbeens #CancerTherapy
Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.
URL list from Monday, Apr. 25 2022
FastStats - Older Persons Health
cdc.gov/nchs/fastats/older-american-health.htm
Trends in Causes of Death among Older Persons in the United States (October 2005)
cdc.gov/nchs/data/ahcd/agingtrends/06olderpersons.pdf
Cancer Immunosurveillance by Tissue-Resident Innate Lymphoid Cells and Innate-like T Cells: Cell
cell.com/cell/fulltext/S0092-8674(16)00003-9
Programme of self-reactive innate-like T cell-mediated cancer immunity | Nature
nature.com/articles/s41586-022-04632-1
Scientists identify potential new 'soldier' for cancer immunotherapy -- ScienceDaily
sciencedaily.com/releases/2022/04/220420133616.htm
About Us | Sloan Kettering Institute
mskcc.org/research/ski/about
New T cell immune response discovery points to ‘out-of-box’ cancer therapy options – Endpoints News
endpts.com/new-t-cell-immune-response-discovery-points-to-out-of-box-cancer-therapy-options
Programme of self-reactive innate-like T cell-mediated cancer immunity
en.x-mol.com/paper/article/1516862209619566592
Immune Checkpoint Inhibitors - National Cancer Institute
cancer.gov/about-cancer/treatment/types/immunotherapy/checkpoint-inhibitors
nci-vol-10396-150.jpg (1500×1200)
cancer.gov/sites/g/files/xnrzdm211/files/styles/cgov_enlarged/public/cgov_image/media_image/2019-09/nci-vol-10396-150.jpg?h=30063a04&itok=DGHB7TA1
Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors - PubMed
pubmed.ncbi.nlm.nih.gov/29990692
Definition of CTLA-4 - NCI Dictionary of Cancer Terms - National Cancer Institute
cancer.gov/publications/dictionaries/cancer-terms/def/ctla-4
776560.jpg (3120×2400)
nci-media.cancer.gov/pdq/media/images/776560.jpg
USCS Data Visualizations - CDC
gis.cdc.gov/Cancer/USCS/#/Demographics
FCER1G - Wikipedia
en.wikipedia.org/wiki/FCER1G










